Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

6.51
Delayed Data
As of 4:00pm ET
 -0.12 / -1.81%
Today’s Change
5.02
Today|||52-Week Range
13.26
-17.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash37.8M65.2M35.8M185.7M
 
 
 
 
 
Short Term Investment Cash-12.7M27.4M-29.4M149.9M
 
 
 
 
 
Cash & Short Term Investments110.1M155.3M124.1M185.7M
 
 
 
 
 
 
ReceivablesReceivables9.3M5.9M3.3M6.5M
 
 
 
 
 
 
InventoriesInventories0.00----3.7M
 
 
 
Current AssetsOther Current Assets9.0M5.5M4.7M5.5M
 
 
 
 
 
Current Assets128.3M166.6M132.1M201.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross25.3M34.9M38.6M51.2M
 
 
 
 
 
Depreciation-19.0M-21.5M-24.1M-29.3M
 
 
 
 
 
Intangible Assets12.8M11.7M11.3M11.0M
 
 
 
 
 
Other Assets13.9M11.8M11.5M11.0M
 
 
 
 
 
Total Assets149.0M192.4M158.7M234.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable283.0K1.9M2.5M5.0M
 
 
 
 
 
Short Term Debt2.4M8.2M13.3M0.00
 
 
 
 
Accrued Expenses17.9M29.0M28.1M37.6M
 
 
 
 
 
Other Current Liabilities30.0M40.3M88.6M89.2M
 
 
 
 
 
Other Liabilities38.5M57.7M111.1M103.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt37.5M103.4M106.8M257.7M
 
 
 
 
 
Deferred Taxes0.00-507.0K-496.0K-1.0M
 
 
 
 
Other Liabilities2.0M1.2M1.2M0.00
 
 
 
 
Total Liabilities155.4M235.5M260.7M418.6M
 
 
 
 
 
 
EquityMinority Interest-477.0K-240.0K-268.0K-170.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity-6.5M-43.5M-102.1M-183.9M
 
 
 
 
 
Total Shareholder Equity-6.5M-43.5M-102.1M-183.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding95.8M102.5M106.7M115.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.